Tag: CB2 Insights

December 11, 2019

CB2 Insights Launches Warrant Incentive Program

CB2 Insights announces a warrant exercise incentive program which has been implemented to encourage the exercise of the Company’s outstanding...
December 3, 2019

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

CB2 Insights (CSE:CBII, OTCQB:CBIIF) announced that it is partnering with Licensed Producer FCM Global.
November 14, 2019

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

CB2 Insights today announced Prad Sekar, CEO of CB2 Insights will be participating in a panel discussion and meeting.
November 8, 2019

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019, Sequential Growth of 29 Percent

CB2 Insights (CSE:CBII; OTCQB:CBIIF) announces its results for the three and nine months ended September 30, 2019.
November 1, 2019

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

CB2 Insights announced preliminary unaudited revenue of approximately $4.2 million for the three months ended September 30, 2019.
October 29, 2019

VIVO and CB2 Insights Enter Technology and Research Partnership

CB2 Insights Inc. announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc.
October 17, 2019

CB2 Insights CEO: CROs Will Lead the Way in Medical Cannabis

CB2 Insights CEO Prad Sekar joined the Investing News Network to talk about big pharma’s role in medical cannabis and...